Pancreatic Cancer Center of Excellence
Our goal is to transform what is considered state-of-the-art in the early detection, diagnosis, prevention and treatment of pancreas cancer.
The timing of our center's research could not be more perfect to capitalize on our new understanding of pancreatic cancer and what it will take to stop this deadly disease.
Pancreas cancer is among the world’s most lethal cancers. Often discovered after it has spread to other organs, the 5-year-survival rate is 13 percent for those for whom the cancer has spread to nearby tissues; that rate drops to 3 percent if the cancer has spread to distant parts of the body.
Internationally Recognized Researcher Named Director
Sunil Hingorani, MD, PhD, a highly accomplished and internationally recognized pancreas cancer researcher and clinician, has been named the inaugural recipient of the Nancy Armitage Pancreas Cancer Presidential Chair and the first director of the Pancreatic Cancer Center of Excellence at UNMC and Nebraska Medicine.
No Time to Waste
We have all-out attack on cancer of the pancreas, including clinical trials aimed at early diagnosis and better outcomes.
